BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17091250)

  • 1. Pharmacokinetic and phase II study of heated intraoperative intraperitoneal melphalan.
    Sugarbaker PH; Stuart OA
    Cancer Chemother Pharmacol; 2007 Feb; 59(2):151-5. PubMed ID: 17091250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model.
    Glehen O; Stuart OA; Mohamed F; Sugarbaker PH
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):79-84. PubMed ID: 15048586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic changes induced by the volume of chemotherapy solution in patients treated with hyperthermic intraperitoneal mitomycin C.
    Sugarbaker PH; Stuart OA; Carmignani CP
    Cancer Chemother Pharmacol; 2006 May; 57(5):703-8. PubMed ID: 16096789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study.
    de Bree E; Rosing H; Filis D; Romanos J; Melisssourgaki M; Daskalakis M; Pilatou M; Sanidas E; Taflampas P; Kalbakis K; Beijnen JH; Tsiftsis DD
    Ann Surg Oncol; 2008 Apr; 15(4):1183-92. PubMed ID: 18239973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heated intraoperative intraperitoneal mitomycin C and early postoperative intraperitoneal 5-fluorouracil: pharmacokinetic studies.
    Jacquet P; Averbach A; Stephens AD; Stuart OA; Chang D; Sugarbaker PH
    Oncology; 1998; 55(2):130-8. PubMed ID: 9499187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pharmacologic analysis of intraoperative intracavitary cancer chemotherapy with doxorubicin.
    Van der Speeten K; Stuart OA; Mahteme H; Sugarbaker PH
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):799-805. PubMed ID: 18654746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy.
    Jacquet P; Stephens AD; Averbach AM; Chang D; Ettinghausen SE; Dalton RR; Steves MA; Sugarbaker PH
    Cancer; 1996 Jun; 77(12):2622-9. PubMed ID: 8640714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of heated intraperitoneal oxaliplatin.
    Ferron G; Dattez S; Gladieff L; Delord JP; Pierre S; Lafont T; Lochon I; Chatelut E
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):679-83. PubMed ID: 18084764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-targeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model.
    Pestieau SR; Stuart OA; Sugarbaker PH
    Eur J Surg Oncol; 2000 Nov; 26(7):696-700. PubMed ID: 11078617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodistribution of doxorubicin-alkylated poly(L-lysine citramide imide) conjugates in an experimental model of peritoneal carcinomatosis after intraperitoneal administration.
    Colombo PE; Boustta M; Poujol S; Pinguet F; Rouanet P; Bressolle F; Vert M
    Eur J Pharm Sci; 2007 May; 31(1):43-52. PubMed ID: 17383164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea.
    Esquivel J
    Cancer J; 2009; 15(3):249-54. PubMed ID: 19556912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two kinds of intraperitoneal chemotherapy following complete cytoreductive surgery of colorectal peritoneal carcinomatosis.
    Elias D; Benizri E; Di Pietrantonio D; Menegon P; Malka D; Raynard B
    Ann Surg Oncol; 2007 Feb; 14(2):509-14. PubMed ID: 17096054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of parietal peritonectomy does not change intraperitoneal chemotherapy pharmacokinetics.
    de Lima Vazquez V; Stuart OA; Mohamed F; Sugarbaker PH
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):108-12. PubMed ID: 12759776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy.
    Sugarbaker PH; Alderman R; Edwards G; Marquardt CE; Gushchin V; Esquivel J; Chang D
    Ann Surg Oncol; 2006 May; 13(5):635-44. PubMed ID: 16523363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solutions.
    Mohamed F; Marchettini P; Stuart OA; Sugarbaker PH
    Cancer Chemother Pharmacol; 2003 Nov; 52(5):405-10. PubMed ID: 12879282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver.
    Vahrmeijer AL; van Dierendonck JH; Keizer HJ; Beijnen JH; Tollenaar RA; Pijl ME; Marinelli A; Kuppen PJ; van Bockel JH; Mulder GJ; van de Velde CJ
    Br J Cancer; 2000 May; 82(9):1539-46. PubMed ID: 10789721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic study of postoperative peritoneal infusion with large bulk heated hypotonic 5-fluorouracil fluid for prevention of recurrence and hepatic metastasis of gastric cancer].
    Lin AD; Sun HY; Qu MW; Wang FJ; Wang JY; Li ZJ
    Ai Zheng; 2002 Apr; 21(4):424-9. PubMed ID: 12452026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study.
    Gesson-Paute A; Ferron G; Thomas F; de Lara EC; Chatelut E; Querleu D
    Ann Surg Oncol; 2008 Jan; 15(1):339-44. PubMed ID: 17943387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
    Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the factors which modify thermal enhancement of melphalan in a spontaneous murine tumor.
    Mohamed F; Stuart OA; Glehen O; Urano M; Sugarbaker PH
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):719-24. PubMed ID: 16614851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.